Isavuconazole (Cresemba®) for the treatment of mucormycosis

Assessment Status Rapid Review Complete
Drug Isavuconazole
Brand Cresemba®
Indication For the treatment of mucormycosis in adult patients for whom amphotericin B is inappropriate.
Assessment Process
Rapid review commissioned 11/04/2016
Rapid review completed 11/05/2016
Rapid review outcome Full Pharmacoeconomic Assessment Not Recommended

The HSE has approved reimbursement following confidential price negotiations: April 2018.